#Japan #Tokyo #Theoria Tech #Company M #MVision health

Collaboration Announcement Between Theoria Technologies and Company M

Theoria Technologies Inc., headquartered in Chiyoda, Tokyo, and Company M, renowned for its AI analysis based on brain MRI technologies, have officially signed a business partnership agreement. This collaboration aims to promote awareness and behavior change regarding brain health through the integration of brain imaging data.

Recent studies indicate that changes related to dementia can quietly begin in individuals aged 30 to 40. Thus, raising awareness and proactive measures against these changes is becoming increasingly vital. This partnership seeks to bring together the advanced brain image analysis capabilities from Company M with Theoria's solutions for lifestyle improvements and behavior changes.

Combining the strengths of both companies will not only provide data and information about brain health but also empower the working-age population to understand their brain's future better and translate that understanding into tangible behavior changes.

Background of the Collaboration

The essence of this partnership lies in a shared vision: creating a society where preparing for dementia risks is normalized, rather than only confronting it after diagnosis. Company M has developed a comprehensive brain analysis AI service, "MVision health," which quantitatively assesses brain atrophy and white matter lesions from MRI images. This innovative approach aims to visualize subtle signs of cerebral distress, allowing for preventive management against dementia before it becomes symptomatic.

Theoria Technologies has focused on crafting systems that support healthcare throughout all life stages—from prevention and early detection to post-diagnosis care. Their service offering, "Sonaeru Package," caters to corporate and municipal clients, encouraging early awareness and lifestyle modifications among the working population.

In recognizing the necessity to observe both cognitive function and structural changes in the brain for early risk identification, the partnership emerged as a means to maximize synergy through the combination of Company M's advanced scientific insights and Theoria's expertise in behavior change.

Together, they aim to create a new normal where early detection of structural brain changes and the reduction of cognitive decline risks become standard practice in society.

Specific Initiatives of the Partnership

The collaboration encompasses several key areas:

• - Development of an Integrated Brain Health Data Platform: Using MRI images, individuals undergoing the "MVision health" program will be able to electronically access reports via Theoria's service, "THEO ONE," allowing for a comprehensive understanding of their brain health indicators.
• - Creating Feedback and Solutions to Encourage Behavior Change: This joint effort will clearly link brain health status with daily lifestyle habits, facilitating a system where individuals can understand their brain health and derive actionable insights for improved living.

In the long term, the partnership aspires to provide predictive insights about brain atrophy and specific lifestyle interventions to mitigate this progression.

Leadership Insights

Company M CEO, Shin Mori: "Accurately monitoring one's brain and body is fundamental for sustainable health management. Medical imaging not only detects diseases but visualizes qualitative changes in organs and the impacts of aging. Company M has pioneered analysis technologies that objectively present the status of major organs, including the brain. The partnership with Theoria is a crucial step toward implementing a new health management approach that bridges 'understanding the brain' with 'transforming daily habits.'"

Theoria Technologies CEO, Kohei Sakata: "Addressing the societal issue of dementia cannot be achieved by a single entity; it requires the collaboration of diverse stakeholders to leverage each other's strengths. This partnership with Company M signifies significant progress toward realizing that goal. By merging advanced brain analysis with behavior change techniques, we aim to create an ecosystem where 'understanding the brain' directly translates into 'transforming lives.'"

Future Outlook

Both organizations aim not only to provide imaging services but to connect advanced brain imaging data with individual behavioral changes. Their efforts will focus on early identification of brain changes among individuals aged 30 and above, as well as collaboration with corporate health management and municipal preventive measures to reduce overall healthcare costs.

About Company M

Founded by the esteemed Shin Mori in June 2021, Company M specializes in the AI analysis of medical imaging. Through its flagship service, "MVision health," they quantify and assess brain atrophy and vascular health indicators. The company's rapid expansion includes its recent launch of "MVision body," which evaluates physical frailty metrics. Their mission remains steadfast: to enhance the well-being and longevity of individuals by providing innovative health services.

About Theoria Technologies

Theoria Technologies is committed to transforming the approach towards dementia via technology. As part of the Eisai Group, they aim to tackle the societal challenges posed by dementia by integrating vast knowledge from various stakeholders. Theoria focuses on comprehensive services from prevention in healthy individuals to post-diagnosis care. For more information, visit Theoria Technologies.